Abstract
Developing a biomaterial that functions as a scaffold (osteoconductor), combined with a growth factor (osteoinductor), is of great interest for clinical application in oral and maxillofacial surgery. Growth hormone (GH) is a good candidate, as it is a major regulator of postnatal bone growth and remodeling. Pure PLGA and 70/30 PLGA/PCL matrices were prepared by the solvent evaporation method, combined or not with GH, and tested for toxicity and cell viability using an MTT assay with NIH3T3 mouse cells (ATCC). Cell toxicity was assessed at 24, 48, 72 h, and 7 days of biomaterial exposure to culture medium. All polymers had high cell viability rates. However, from 48 h onwards, the groups with GH-polymer combinations had better results than the polymer groups without association with GH when compared to the control group. At 7 days of culture, only the pure PLGA matrix showed a significant difference from the control group. These results may suggest a preference of cells for the presence of GH in the biomaterial in culture medium, especially in the PLGA matrix. GH appeared to contribute to the increase in cell viability observed at some assessment time points, especially when combined with PLGA as compared to pure PLGA.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
